Author/Authors :
Mortazavi, Hossein Department of Dermatology - Tehran University of Medical Sciences - Razi Hospital, Tehran, Iran , Mortazavi, Alireza Department of Clinical Pharmacy - School of Pharmacy - Tehran University of Medical Sciences, Tehran, Iran , Rostami, Anahita Department of Dermatology - Tehran University of Medical Sciences - Razi Hospital, Tehran, Iran , Javadi, Mohammadreza Department of Clinical Pharmacy - School of Pharmacy - Tehran University of Medical Sciences, Tehran, Iran - Research Center of Rational Use of Drugs - Tehran University of Medical Sciences, Tehran, Iran , Abedini, Robabeh Department of Dermatology - Tehran University of Medical Sciences - Razi Hospital, Tehran, Iran , Teimourpour, Amir Center for Research and Training in Skin Diseases and Leprosy - Tehran University of Medical Sciences, Tehran, Iran , Gholami, Kheirolah Department of Clinical Pharmacy - School of Pharmacy - Tehran University of Medical Sciences, Tehran, Iran - Research Center of Rational Use of Drugs - Tehran University of Medical Sciences, Tehran, Iran , Khamesipour, Ali Center for Research and Training in Skin Diseases and Leprosy - Tehran University of Medical Sciences, Tehran, Iran
Abstract :
Background: Little data on severe cutaneous adverse drug reactions (SCADRs) is available, especially in Iran. Therefore, there is a need for more studies in this field. We aimed to evaluate the
clinical pictures and laboratory data of patients with SCADR in
a tertiary dermatology center in Tehran, Iran.
Methods: In this retrospective study, patients with a clinical
diagnosis of SCADR based on the World Health Organisation’s definition and histopathologic findings were included. Causality
and preventability measures were assessed based on previous
criteria, including the Naranjo score and the Schomock and
Thronton scale.
Results: Thirty-nine patients with a mean age of 43 ± 17
years participated in the study. SCADRs were more common
in females than in males (2.9/1). SCADRs included Stevens-
Johnson syndrome/toxic epidermal necrolysis (SJS/TEN), acute
generalized exanthematous pustulosis (AGEP), and drug reactions
with eosinophilia and systemic symptoms (DRESS). Thirty-one
patients presented a Naranjo score of 5-8, indicating probable
drug reactions. The remaining eight patients (with scores of 1-4)
were determined as having possible drug eruptions. Regarding
the category of culprit drugs, anticonvulsants (49%), antimalarials
(15%), antibiotics (13%), and antihypertensives (10%) were the
most frequent causes of SCADR, with lamotrigine being the
single most common agent.
Conclusion: The most frequent clinical presentation of SCADR
was SJS/TEN, followed by AGEP and DRESS. The most frequent cause of SCADR was anticonvulsant drugs.
Keywords :
adverse drug reaction reporting system , anticonvulsant , antimalarial , antibiotic